What's new

Overview of comments received on ICH M11 technical specification during second consultation (EMA/CHMP/ICH/778800/2022)

Overview of comments received on ICH M11 technical specification during second consultation (EMA/CHMP/ICH/778800/2022)

May 23, 2025 - 13:35
 0
Overview of comments received on ICH M11 technical specification during second consultation (EMA/CHMP/ICH/778800/2022)
Read More

Tags:

Previous Article

ICH M11 guideline, clinical study protocol template and technical specifications...

Next Article

Consumer safety of active substances of immunological veterinary medicinal produ...

Related Posts

Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Xyrem, sodium oxybate, Date of authorisation: 13/10/2005, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

European Shortages Monitoring Platform (ESMP) User guid...

May 13, 2025  0